DGX
Quest Diagnostics, Inc.
NYSE · Healthcare · Medical - Diagnostics & Research · US
$247.06
−1.50%Margins
Gross margin
33.1%
EBITDA margin
19.4%
EBIT margin
14.6%
Net margin
9.5%
FCF margin
11.6%
14.8%
Return on equity
6.6%
Return on assets
12.4%
Return on invested capital
0.69x
Asset turnover
$2.0B
Cash from operations
$7.25
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Sep 1, 2026